Inherited non-medullary thyroid cancer
Gene: BRAFEnsemblGeneIds (GRCh38): ENSG00000157764
EnsemblGeneIds (GRCh37): ENSG00000157764
OMIM: 164757, Gene2Phenotype
BRAF is in 24 panels
1 review
Sarah Leigh (Genomics England Curator)
Comment when marking as ready: Associated with phenotype in OMIM, not in G2P. At least one variant reported in two patients.Created: 31 Jul 2017, 10:53 a.m.
Single variant identified in two members of one family (PMID 26530882).Created: 31 Jul 2017, 10:50 a.m.
Mode of inheritance
Unknown
Phenotypes
Familial Non-medullary Thyroid Cancer
Publications
Details
- Mode of Inheritance
- Unknown
- Sources
-
- Expert Review Red
- Literature
- Phenotypes
-
- Familial Non-medullary Thyroid Cancer
- OMIM
- 164757
- Clinvar variants
- Variants in BRAF
- Penetrance
- Complete
- Publications
- Panels with this gene
-
- Monogenic short stature
- Childhood solid tumours cancer susceptibility
- Intellectual disability
- Early onset or syndromic epilepsy
- Adult solid tumours cancer susceptibility
- Pituitary hormone deficiency
- Paediatric or syndromic cardiomyopathy
- Pigmentary skin disorders
- Cytopenias and congenital anaemias
- Rare syndromic craniosynostosis or isolated multisuture synostosis
- Primary lymphoedema
- Fetal hydrops
- Neurofibromatosis Type 1
- Hypertrophic cardiomyopathy
- Mosaic skin disorders - Deep sequencing
- Hereditary neuropathy
- RASopathies
- IUGR and IGF abnormalities
- Hereditary neuropathy or pain disorder
- Childhood solid tumours
- Multiple monogenic benign skin tumours
- Inherited non-medullary thyroid cancer
- DDG2P
- Fetal anomalies
History Filter Activity
panel promoted to version 1
Sarah Leigh (Genomics England Curator)All genes have been reviewed and the reviews evaluated. 07.08.2017
Gene classified by Genomics England curator
Sarah Leigh (Genomics England Curator)This gene has been classified as Red List (Low Evidence).
Created
Sarah Leigh (Genomics England Curator)BRAF was created by sleigh
Added New Source
Sarah Leigh (Genomics England Curator)BRAF was added to Inherited non-medullary thyroid cancerpanel. Sources: Literature